Breaking News Instant updates and real-time market news.

BUD

AB InBev

$53.87 /

-1.23 (-2.23%)

 12:07
07/05/22
 07/05
12:07
 07/05/22
12:07

AB InBev price target lowered to EUR 73 from EUR 74 at Deutsche Bank

Deutsche Bank analyst Mitch Collett lowered the firm's price target on AB InBev to EUR 73 from EUR 74 and keeps a Buy rating on the shares.

  • 28

    Jul

  • 19

    Sep

OTHER BREAKING NEWS FROM THE FLY

Earnings
Target Hospitality reports Q2 EPS 24c, consensus 17c » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TH

Target Hospitality

$13.97 /

+0.12 (+0.87%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

07/07/22
Target Hospitality announces expanded humanitarian contract
05/25/22
Target Hospitality CEO Brad Archer to remain in position through 2025
03/29/22
Target Hospitality Corp trading resumes
03/29/22
Target Hospitality Corp trading halted, volatility trading pause
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

07/12/22 Oppenheimer
Target Hospitality price target raised to $18 from $9 at Oppenheimer
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

07/08/22
Target Hospitality raises FY22 revenue view to $500M-$510M from $325M-$335M
07/08/22
Target Hospitality sees Q2 revenue $102M-$107M, consensus $82.67M
05/10/22
Target Hospitality sees FY22 revenue $325M-$335M, consensus $332.1M
05/10/22
Target Hospitality reports Q1 EPS 1c, consensus 1c
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

07/08/22
What You Missed On Wall Street On Friday
07/08/22
What You Missed On Wall Street This Morning
07/08/22
Fly Intel: Pre-market Movers
09:00 Today
Target Hospitality - TH
09/13/22
Target Hospitality
09/14/22
Target Hospitality
Recommendations
Enanta price target raised to $137 from $103 at JMP Securities » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
ENTA

Enanta

$71.21 /

+0.39 (+0.55%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

07/29/22
Enanta announces data from Phase 1 study of EDP-235
06/21/22
Enanta files patent infringement lawsuit against Pfizer
05/18/22
Enanta falls 13% after announcing EDP-938 did not meet primary endpoint
05/18/22
Enanta says EDP-938 did not meet primary endpoint in RSVP study
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

08/01/22 Oppenheimer
Enanta price target raised to $53 from $45 at Oppenheimer
07/29/22 Piper Sandler
Enanta's 'strong' EDP-235 data supports 'impressive' profile, says Piper Sandler
07/06/22 Evercore ISI
Enanta upgraded to Outperform at Evercore ISI ahead of COVID anti-viral data
07/06/22 Evercore ISI
Enanta upgraded to Outperform from In Line at Evercore ISI
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

08/08/22
Enanta reports Q3 EPS ($1.53), consensus ($1.39)
05/09/22
Enanta reports Q2 EPS ($1.63), consensus ($1.43)
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

07/06/22
What You Missed On Wall Street On Wednesday
07/06/22
What You Missed On Wall Street This Morning
07/06/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
05/18/22
Fly Intel: After-Hours Movers
Earnings
Capri Holdings sees FY23 EPS $6.85, consensus $6.74 » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
CPRI

Capri Holdings

$51.01 /

+1.38 (+2.78%)

Sees FY23 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/20/22
Capri Holdings sees forex headwinds of $300M in FY23
07/20/22
Capri Holdings interested in 'fashion luxury' acquisitions
07/20/22
Capri Holdings targets long-term operating margin about 20%
07/20/22
Capri Holdings up 2% as revenue targets discussed during investor day
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/28/22 Barclays
Capri Holdings price target raised to $66 from $63 at Barclays
07/21/22 Credit Suisse
Capri Holdings price target lowered to $56 from $65 at Credit Suisse
07/21/22 Goldman Sachs
Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
07/15/22 UBS
Capri Holdings price target lowered to $65 from $91 at UBS
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

06:47 Today
Capri Holdings reports Q1 adjusted EPS $1.50, consensus $1.36
07/20/22
Capri Holdings backs FY23 EPS view $6.85, consensus $6.83
06/01/22
Capri Holdings provides quarterly FY23 guidance
06/01/22
Capri Holdings sees Q1 EPS $1.35, consensus $1.45
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/20/22
What You Missed On Wall Street On Wednesday
07/20/22
What You Missed On Wall Street This Morning
06/01/22
What You Missed On Wall Street On Wednesday
06/01/22
What You Missed On Wall Street This Morning
08:30 Today
Capri Holdings - CPRI
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/25/22
Largest borrow rate increases among liquid names
06/30/22
Capri Holdings call volume above normal and directionally bullish
06/16/22
Capri Holdings call volume above normal and directionally bullish
06/13/22
Capri Holdings call volume above normal and directionally bullish
Recommendations
Tyson Foods price target lowered to $95 from $100 at Stephens » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TSN

Tyson Foods

$80.10 /

-7.395 (-8.45%)

Stephens analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

08/08/22
Tyson Foods: Demand for chicken 'extremely strong'
08/08/22
Tyson: Prepared fods unit can't fulfill all orders due to supply constraints
08/08/22
Tyson Foods CEO says demand 'relatively steady'
08/08/22
Tyson Foods focused on overcoming supply chain challenges, says CEO
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

06:16 Today BMO Capital
Tyson Foods price target lowered to $90 from $99 at BMO Capital
05:55 Today Barclays
Tyson Foods price target lowered to $89 from $100 at Barclays
04:57 Today Piper Sandler
Piper upgrades Tyson Foods to Neutral with risks priced in
08/08/22 Piper Sandler
Tyson Foods upgraded to Neutral from Underweight at Piper Sandler
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

08/08/22
Tyson Foods sees 2022 revenue $52B-$54B, consensus $52.8B
08/08/22
Tyson Foods reports Q3 adjusted EPS $1.94 vs. $2.70 last year
07/06/22
Tyson Foods buys strategic stake in Tanmiah of Saudi Arabia
05/09/22
Tyson Foods raises FY22 revenue view to $52B-$54B from $49B-$51B
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

08/03/22
NY AG says Tyson ignoring subpoena for meat price investigation, Reuters says
07/11/22
Tyson Foods works to fix operations as it falls behind competitors, WSJ reports
02/15/22
Tyson Foods to ease mask rules at some processing plants, NY Times reports
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

08/08/22
What You Missed On Wall Street On Monday
08/08/22
What You Missed On Wall Street This Morning
08/08/22
Fly Intel: Pre-market Movers
07/11/22
What You Missed On Wall Street On Monday
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

08/08/22
Unusually active option classes on open August 8th
03/14/22
Unusually active option classes on open March 14th
03/04/22
Tyson Foods put volume heavy and directionally bearish
03/02/22
Unusually active option classes on open March 2nd
Recommendations
Reata Pharmaceuticals price target lowered to $27 from $37 at Baird » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
RETA

Reata Pharmaceuticals

$24.02 /

-11.895 (-33.12%)

Baird analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

08/08/22
Reata CEO looks forward to working with FDA on review of omaveloxone NDA
08/08/22
Reata Pharmaceuticals trading resumes
08/08/22
Reata Pharmaceuticals trading halted, volatility trading pause
05/26/22
Reata Pharmaceuticals' NDA for omaveloxolone granted Priority Review by FDA
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

08/08/22 Goldman Sachs
Reata sinks on Friedreich's ataxia update but Goldman remains positive
08/08/22 Goldman Sachs
Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs
05/27/22 Citi
Reata Pharmaceuticals price target raised to $46 from $43 at Citi
05/11/22 Ladenburg
Reata Pharmaceuticals price target lowered to $67 from $75 at Ladenburg
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

08/08/22
Reata Pharmaceuticals reports Q2 EPS ($2.02) , consensus ($2.02)
05/10/22
Reata Pharmaceuticals reports Q1 adjusted EPS ($1.33), consensus ($2.15)
02/28/22
Reata Pharmaceuticals reports Q4 EPS ($2.35), consensus ($2.31)
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

08/08/22
What You Missed On Wall Street On Monday
08/08/22
What You Missed On Wall Street This Morning
02/28/22
What You Missed On Wall Street This Morning
11/30/22
PDUFA Date for Omaveloxolone
Hot Stocks
Wireless Telecom sees Q3 bookings $8M-$10M » 06:48
08/09/22
08/09
06:48
08/09/22
06:48
WTT

Wireless Telecom

$1.56 /

+0.08 (+5.41%)

Tim Whelan, CEO of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

07/25/22
CommAgility introduces 5G Network Listening Mode software
06/21/22
Wireless Telecom's Noisecom introduces 60 GHz jitter noise generator
06/15/22
Wireless Telecom to showcase specialized solutions at IMS 2022
05/26/22
Wireless Telecom's Boonton introduces NGX1000 Programmable Noise Generator
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

06:46 Today
Wireless Telecom reports Q2 cont ops EPS (6c), consensus (4c)
03/17/22
Wireless Telecom reports Q4 EPS 2c vs. (25c) a year ago
02/10/22
Wireless Telecom sees Q4 revenue $13.1M, consensus $13.39M
08:30 Today
Wireless Telecom - WTT
Earnings
Capri Holdings reports Q1 adjusted EPS $1.50, consensus $1.36 » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
CPRI

Capri Holdings

$51.01 /

+1.38 (+2.78%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/20/22
Capri Holdings sees forex headwinds of $300M in FY23
07/20/22
Capri Holdings interested in 'fashion luxury' acquisitions
07/20/22
Capri Holdings targets long-term operating margin about 20%
07/20/22
Capri Holdings up 2% as revenue targets discussed during investor day
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/28/22 Barclays
Capri Holdings price target raised to $66 from $63 at Barclays
07/21/22 Credit Suisse
Capri Holdings price target lowered to $56 from $65 at Credit Suisse
07/21/22 Goldman Sachs
Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
07/15/22 UBS
Capri Holdings price target lowered to $65 from $91 at UBS
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/20/22
Capri Holdings backs FY23 EPS view $6.85, consensus $6.83
06/01/22
Capri Holdings provides quarterly FY23 guidance
06/01/22
Capri Holdings sees Q1 EPS $1.35, consensus $1.45
06/01/22
Capri Holdings sees FY23 EPS $6.85, consensus $6.57
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/20/22
What You Missed On Wall Street On Wednesday
07/20/22
What You Missed On Wall Street This Morning
06/01/22
What You Missed On Wall Street On Wednesday
06/01/22
What You Missed On Wall Street This Morning
08:30 Today
Capri Holdings - CPRI
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/25/22
Largest borrow rate increases among liquid names
06/30/22
Capri Holdings call volume above normal and directionally bullish
06/16/22
Capri Holdings call volume above normal and directionally bullish
06/13/22
Capri Holdings call volume above normal and directionally bullish
Hot Stocks
Planet Fitness announces Jamie Medeiros as chief brand officer » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
PLNT

Planet Fitness

$81.08 /

+0.71 (+0.88%)

Planet Fitness announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

05/25/22
Blue Apron adds partnerships with Blue Cross Blue Shield, Planet Fitness
05/10/22
Planet Fitness announces development agreement in New Zealand
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22 Exane BNP Paribas
Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas
06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
06/07/22 Cowen
Planet Fitness positioned to succeed despite macro challenges, says Cowen
05/25/22 Cowen
Planet Fitness operating model remains resilient among headwinds, says Cowen
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

06:40 Today
Planet Fitness sees FY22 adjusted EPS up mid-80% range
06:37 Today
Planet Fitness reports Q2 adjusted EPS 38c vs. 21c last year
05/10/22
Planet Fitness sees 2022 revenue increasing in mid-50 percent range
05/10/22
Planet Fitness reports Q1 adjusted EPS 32c, consensus 27c
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
05/11/22
What You Missed On Wall Street On Wednesday
05/11/22
What You Missed On Wall Street This Morning
05/11/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
08:00 Today
Planet Fitness - PLNT
Recommendations
Mersana Therapeutics price target raised to $20 from $18 at Baird » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
MRSN

Mersana Therapeutics

$5.24 /

+0.215 (+4.28%)

, GSK

GSK plc

$40.31 /

-0.27 (-0.67%)

Baird analyst Collen Kusy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

08/08/22
Mersana to get $100M upfront fee from GSK for co-commercialization of XMT-2056
08/08/22
Mersana Therapeutics trading resumes
08/08/22
Mersana Therapeutics trading halted, news pending
05/23/22
Mersana Therapeutics director Hack buys 216K shares of stock
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

08/08/22
Mersana to get $100M upfront fee from GSK for co-commercialization of XMT-2056
08/08/22
GSK, IQVIA launch Vaccine Track platform
07/29/22
ViiV Healthcare presents five-year data at AIDS 2022 on fostemsavir
07/28/22
ViiV Healthcare announces data from unblinded phase of HPTN 084 study
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

05/10/22 Baird
Mersana Therapeutics price target lowered to $18 from $23 at Baird
05/09/22 H.C. Wainwright
Mersana price target lowered to $19 from $24 at H.C. Wainwright
11/10/21 Baird
Mersana Therapeutics price target lowered to $23 from $30 at Baird
10/14/21 BTIG
Mersana Therapeutics assumed with a Buy at BTIG
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
08/05/22 Morgan Stanley
GSK plc resumed with an Equal Weight at Morgan Stanley
07/21/22 Citi
GSK plc resumed with a Neutral at Citi
07/20/22 UBS
GSK plc price target lowered to 1,850 GBp from 1,876 GBp at UBS
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

08/08/22
Mersana Therapeutics reports Q2 EPS (55c), consensus (52c)
05/09/22
Mersana Therapeutics reports Q1 EPS (59c), consensus (32c)
02/28/22
Mersana Therapeutics reports Q4 EPS (68c), consensus (67c)
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

07/27/22
GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year
04/27/22
GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER
04/27/22
GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year
04/13/22
GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

07/18/22
GSK CEO says split will help deal with 'perennial underperformance,' FT reports
06/27/22
GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says
06/27/22
GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says
06/06/22
GSK rectal cancer trial yields remission in all 18 patients, NY Times reports
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

08/08/22
Fly Intel: After-Hours Movers
04/14/22
What You Missed On Wall Street This Morning
02/09/22
Wall Street in Fives - Must Read Lists for Wednesday
02/09/22
Wall Street in Fives - Must Read Lists at Midday
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

08/05/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
07/18/22
What You Missed On Wall Street This Morning
07/18/22
Fly Intel: Pre-market Movers
06/24/22
What You Missed On Wall Street On Friday
06/08/22
Global Healthcare Conference
00:00 Today
Wedbush PacGrow Healthcare Virtual Conference
09/10/22
ESMO Congress 2022
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

07/29/22
GSK plc (ADR) call volume above normal and directionally bullish
07/22/22
Two new option listings and one option delisting on July 22nd
07/20/22
One new option listing and two option delistings on July 20th
07/08/22
GlaxoSmithKline call volume above normal and directionally bullish
Earnings
Wireless Telecom reports Q2 cont ops EPS (6c), consensus (4c) » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
WTT

Wireless Telecom

$1.56 /

+0.08 (+5.41%)

Reports Q2 revenue $6.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

07/25/22
CommAgility introduces 5G Network Listening Mode software
06/21/22
Wireless Telecom's Noisecom introduces 60 GHz jitter noise generator
06/15/22
Wireless Telecom to showcase specialized solutions at IMS 2022
05/26/22
Wireless Telecom's Boonton introduces NGX1000 Programmable Noise Generator
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

03/17/22
Wireless Telecom reports Q4 EPS 2c vs. (25c) a year ago
02/10/22
Wireless Telecom sees Q4 revenue $13.1M, consensus $13.39M
08:30 Today
Wireless Telecom - WTT
Recommendations
Scholar Rock price target lowered to $43 from $55 at BMO Capital » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
SRRK

Scholar Rock

$8.54 /

+0.035 (+0.41%)

BMO Capital analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

06/17/22
Scholar Rock announces new data from TOPAZ trial extension period
05/16/22
Scholar Rock announces 25% workforce reduction
05/16/22
Scholar Rock Chief Medical Officer to step down
SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

07/12/22 Truist
Scholar Rock initiated with a Buy at Truist
06/23/22 Piper Sandler
Scholar Rock price target lowered to $19 from $28 at Piper Sandler
05/24/22 JPMorgan
Scholar Rock price target lowered to $37 from $46 at JPMorgan
05/17/22 BMO Capital
Scholar Rock price target lowered to $55 from $74 at BMO Capital
SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

08/08/22
Scholar Rock reports Q2 EPS ($1.06), consensus ($1.03)
05/16/22
Scholar Rock reports Q1 EPS (21c), consensus (62c)
03/07/22
Scholar Rock reports FY21 EPS ($3.59), consensus ($3.67)
00:00 Today
Wedbush PacGrow Healthcare Virtual Conference
Hot Stocks
Hormel Foods announces new operating model » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
HRL

Hormel Foods

$49.03 /

+0.105 (+0.21%)

Hormel Foods announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

03/15/22 Goldman Sachs
Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
03/10/22 Argus
Hormel Foods upgraded to Buy at Argus on pricing power
03/10/22 Argus
Hormel Foods upgraded to Buy from Hold at Argus
01/25/22 Piper Sandler
Hormel Foods price target lowered to $48 from $49 at Piper Sandler
HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

06/02/22
Hormel Foods cuts FY22 EPS view to $1.87-$1.97 from $1.87-$2.03
06/02/22
Hormel Foods reports Q2 EPS 48c, consensus 47c
06/01/22
Notable companies reporting before tomorrow's open
06/01/22
Notable companies reporting before tomorrow's open
HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

06/02/22
What You Missed On Wall Street On Thursday
06/02/22
What You Missed On Wall Street This Morning
03/15/22
What You Missed On Wall Street On Tuesday
03/15/22
What You Missed On Wall Street This Morning
09/01/22
Hormel Foods - HRL
HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

03/01/22
Early notable gainers among liquid option names on March 1st
Downgrade
Nike downgraded to Neutral at Exane BNP Paribas on concerns about FY25 targets » 06:44
08/09/22
08/09
06:44
08/09/22
06:44
NKE

Nike

$114.01 /

+0.13 (+0.11%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$114.01 /

+0.13 (+0.11%)

07/27/22
CarGurus appoints Javier Zamora as general counsel
07/19/22
Skechers down 4% as short-seller Spruce Point sees 30%-50% downside risk
06/27/22
Nike says taking 'cautious approach' to greater China in FY23
06/27/22
Nike says digital now represents 24% of brand revenue
NKE Nike
$114.01 /

+0.13 (+0.11%)

05:30 Today Exane BNP Paribas
Nike downgraded to Neutral from Outperform at Exane BNP Paribas
07/25/22 Piper Sandler
Nike assumed with a Neutral at Piper Sandler
07/21/22 KeyBanc
KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view
07/20/22 KeyBanc
Nike initiated with a Sector Weight at KeyBanc
NKE Nike
$114.01 /

+0.13 (+0.11%)

06/27/22
Nike sees Q1 revenue growth flat to slightly up sequentially, consensus $12.88B
06/27/22
Nike sees FY23 revenue growth in low double digits, consensus $51.57B
06/27/22
Nike reports Q4 EPS 90c, consensus 81c
06/27/22
Notable companies reporting after market close
NKE Nike
$114.01 /

+0.13 (+0.11%)

06/23/22
Cisco, Nike planning to fully exit Russia, Reuters reports
05/24/22
Nike not renewing franchise deal with IRG, will leave Russia, Vedomosti says
05/18/22
Nike's head of diversity to leave at end of July, FT reports
03/19/22
Nike reports earnings Monday, investors shouldn't get hopes up, Barron's says
NKE Nike
$114.01 /

+0.13 (+0.11%)

07/11/22
Game On: Wedbush's Pachter calls GameStop chairman 'deluded'
06/28/22
What You Missed On Wall Street On Tuesday
06/28/22
What You Missed On Wall Street This Morning
06/28/22
Fly Intel: Pre-market Movers
09/09/22
Nike Inc.
NKE Nike
$114.01 /

+0.13 (+0.11%)

07/05/22
Early notable gainers among liquid option names on July 5th
06/29/22
Early notable gainers among liquid option names on June 29th
06/27/22
Nike options imply 8.0% move in share price post-earnings
06/27/22
Unusually active option classes on open June 27th
Earnings
Vivid Seats raises FY22 revenue view to $540.0M-$570.0M from $520.0M-$555.0M » 06:44
08/09/22
08/09
06:44
08/09/22
06:44
SEAT

Vivid Seats

$8.70 /

+0.18 (+2.11%)

Consensus is for FY22…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

07/27/22
Vivid Seats, Rolling Stone announce a multi-faceted partnership
06/30/22
Vivid Seats announces expiration, results of exchange offer
06/16/22
Vivid Seats to join Russell 2000, Russell 3000 Indexes
05/26/22
Vivid Seats board authorizes $40M share repurchase program
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

07/14/22 Piper Sandler
Vivid Seats initiated with a Neutral at Piper Sandler
07/07/22 Citi
Vivid Seats price target lowered to $12 from $14 at Citi
05/10/22 Raymond James
Vivid Seats price target lowered to $11 from $17 at Raymond James
03/11/22 Benchmark
Vivid Seats price target lowered to $17 from $19 at Benchmark
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

06:42 Today
Vivid Seats reports Q2 rvenue $147.7M, consensus $125.4M
05/10/22
Vivid Seats raises FY22 revenue view to $520.0M-$555.0M from $510.0M-$550.0M
05/10/22
Vivid Seats reports Q1 revenue $130.8M, consensus $113.83M
03/10/22
Vivid Seats sees 2022 revenue $510M-$550M, consensus $554.44M
08/08/22
42nd Annual Global I Growth Conference
09/08/22
Consumer/Media/Entertainment Conference
08:30 Today
Vivid Seats - SEAT
Recommendations
Castle Biosciences price target raised to $48 from $44 at Baird » 06:44
08/09/22
08/09
06:44
08/09/22
06:44
CSTL

Castle Biosciences

$28.33 /

-2.34 (-7.63%)

Baird analyst Catherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

07/25/22
Castle Biosciences announces DecisionDx-Melanoma surpasses 100,000 tests ordered
06/22/22
Castle Biosciences announces data showing value of skin cancer tests
05/24/22
Castle Biosciences announces results from TissueCypher Barrett's Esophagus study
05/19/22
Castle Biosciences' DecisionDx-SCC shows risk-stratification efficacy in study
CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

05/19/22 Baird
Baird says final LCD for test 'incrementally positive' for Castle Biosciences
05/10/22 Canaccord
Castle Biosciences price target lowered to $65 from $80 at Canaccord
05/10/22 Baird
Castle Biosciences price target lowered to $44 from $50 at Baird
05/09/22 BTIG
Castle Biosciences transferred with a Buy at BTIG
CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

08/08/22
Castle Biosciences raises FY22 revenue view to $130M-$135M from $118M-$123M
08/08/22
Castle Biosciences reports Q2 EPS (6c), consensus (76c)
05/09/22
Castle Biosciences raises FY22 revenue view to $118M-$123M from $115M-$120M
05/09/22
Castle Biosciences reports Q1 EPS (97c), consensus (71c)
CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

04/04/22
Fly Intel: After-Hours Movers
08/08/22
42nd Annual Global I Growth Conference
09/14/22
6th Annual Best Ideas Growth Conference: Big 6
Hot Stocks
Nielsen postpones court, special meeting regarding acquisition by consortium » 06:43
08/09/22
08/09
06:43
08/09/22
06:43
NLSN

Nielsen

$22.71 /

-0.33 (-1.43%)

Nielsen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

07/29/22
Nielsen receives regulatory approval for proposed transaction
07/25/22
ISS recommends Nielsen holders vote 'FOR' proposed transaction
06/16/22
Magnite expands measurement, attribution program for currency optionality
05/16/22
Elliott adds Diamond Offshore, exits Arconic in Q1
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

05/16/22 BMO Capital
Nielsen downgraded to Market Perform from Outperform at BMO Capital
03/30/22 Jefferies
Nielsen downgraded to Hold from Buy at Jefferies
03/29/22 Morgan Stanley
Morgan Stanley raises Nielsen to Equal Weight, says 'may be better off private'
03/29/22 Morgan Stanley
Nielsen upgraded to Equal Weight from Underweight at Morgan Stanley
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

07/27/22
Nielsen backs FY22 adjusted EPS $1.81-$1.91, consensus $1.88
07/27/22
Nielsen reports Q2 adjusted EPS 46c, consensus 43c
04/28/22
Nielsen backs FY22 adjusted EPS $1.81-$1.91, consensus $1.83
04/28/22
Nielsen reports Q1 adjusted EPS 45c, consensus 40c
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

04/22/22
U.K. probing WindAcre stake in Nielsen, Bloomberg reports
04/07/22
WindAcre offer to support Nielsen buyout quickly rejected, Bloomberg says
03/22/22
Elliott, Brookfield mull raising offer for Nielsen, Bloomberg reports
03/22/22
Elliott, Brookfield mull raising offer for Nielsen, Bloomberg reports
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

05/16/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
03/30/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
03/29/22
What You Missed On Wall Street On Tuesday
03/29/22
What You Missed On Wall Street This Morning
08:15 Today
Nielsen Holdings plc
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

03/29/22
Early notable gainers among liquid option names on March 29th
03/22/22
Nielsen call volume above normal and directionally bullish
Earnings
Hain Celestial sees FY23 low single digit adjusted net sales growth » 06:43
08/09/22
08/09
06:43
08/09/22
06:43
HAIN

Hain Celestial

$23.08 /

+0.1 (+0.44%)

FY23 outlook: The company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

06/16/22 Piper Sandler
Hain Celestial price target lowered to $31 from $36 at Piper Sandler
05/24/22 CL King
Hain Celestial initiated with a Buy at CL King
05/23/22 Cowen
Hain Celestial initiated with an Outperform at Cowen
05/09/22 Mizuho
Hain Celestial price target lowered to $31 from $44 at Mizuho
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

06:41 Today
Hain Celestial sees Q4 revenue approximately $457M, consensus $478.45M
05/05/22
Hain Celestial sees 2022 flat adjusted net sales, consensus $1.95B
05/05/22
Hain Celestial sees Q4 low to mid single digital adjusted net sales growth
05/05/22
Hain Celestial reports Q3 adjusted EPS 33c, consensus 45c
  • 11
    Nov
Recommendations
Targa Resources price target raised to $91 from $87 at Mizuho » 06:42
08/09/22
08/09
06:42
08/09/22
06:42
TRGP

Targa Resources

$65.03 /

+1.275 (+2.00%)

Mizuho analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

06/16/22
Targa Resources expects Lucid acquisition to be accretive to cash flow per share
06/16/22
Targa Resources now sees FY22 adjusted EBITDA $2.68B-$2.78B
06/16/22
Targa Resources to acquire Lucid Energy for $3.55B
04/21/22
Targa Resources completes acquisition of Southcross Energy Operating LLC
TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

07/20/22 Barclays
Targa Resources price target lowered to $87 from $92 at Barclays
07/12/22 RBC Capital
Targa Resources price target raised to $100 from $90 at RBC Capital
05/02/22 Truist
Targa Resources assumed with a Buy at Truist
04/26/22 Morgan Stanley
Targa Resources price target raised to $103 from $74 at Morgan Stanley
TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

08/04/22
Targa Resources raises 2022 adj EBITDA view to $2.85B-$2.95B from $2.68B-$2.78B
08/04/22
Targa Resources reports Q2 revenue $6.06B, consensus $5.82B
05/05/22
Targa Resources reports Q1 revenue $4.96B, consensus $4.87B
02/24/22
Targa Resources revenue $5.44B, consensus $4.19B
TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

06/16/22
Fly Intel: After-Hours Movers
Earnings
Vivid Seats reports Q2 rvenue $147.7M, consensus $125.4M » 06:42
08/09/22
08/09
06:42
08/09/22
06:42
SEAT

Vivid Seats

$8.70 /

+0.18 (+2.11%)

Reports Q2 Adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

07/27/22
Vivid Seats, Rolling Stone announce a multi-faceted partnership
06/30/22
Vivid Seats announces expiration, results of exchange offer
06/16/22
Vivid Seats to join Russell 2000, Russell 3000 Indexes
05/26/22
Vivid Seats board authorizes $40M share repurchase program
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

07/14/22 Piper Sandler
Vivid Seats initiated with a Neutral at Piper Sandler
07/07/22 Citi
Vivid Seats price target lowered to $12 from $14 at Citi
05/10/22 Raymond James
Vivid Seats price target lowered to $11 from $17 at Raymond James
03/11/22 Benchmark
Vivid Seats price target lowered to $17 from $19 at Benchmark
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

05/10/22
Vivid Seats raises FY22 revenue view to $520.0M-$555.0M from $510.0M-$550.0M
05/10/22
Vivid Seats reports Q1 revenue $130.8M, consensus $113.83M
03/10/22
Vivid Seats sees 2022 revenue $510M-$550M, consensus $554.44M
03/10/22
Vivid Seats reports Q4 revenue $163.9M, consensus $139.54M
08/08/22
42nd Annual Global I Growth Conference
09/08/22
Consumer/Media/Entertainment Conference
08:30 Today
Vivid Seats - SEAT
Recommendations
Pinnacle West price target raised to $77 from $76 at Mizuho » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
PNW

Pinnacle West

$75.60 /

+0.215 (+0.29%)

Mizuho analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNW Pinnacle West
$75.60 /

+0.215 (+0.29%)

07/18/22 Barclays
Pinnacle West price target lowered to $68 from $78 at Barclays
06/30/22 UBS
Pinnacle West price target lowered to $67 from $74 at UBS
04/25/22 Credit Suisse
Pinnacle West initiated with an Underperform at Credit Suisse
04/19/22 Barclays
Pinnacle West downgraded to Underweight from Equal Weight at Barclays
PNW Pinnacle West
$75.60 /

+0.215 (+0.29%)

08/03/22
Pinnacle West backs FY22 EPS view of $3.90-$4.10, consensus $4.02
08/03/22
Pinnacle West reports Q2 EPS $1.45, consensus $1.32
05/04/22
Pinnacle West sees FY22 EPS $3.90-$4.10, consensus $4.02
05/04/22
Pinnacle West reports Q1 EPS 15c, consensus 6c
Earnings
Hain Celestial sees Q4 revenue approximately $457M, consensus $478.45M » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
HAIN

Hain Celestial

$23.08 /

+0.1 (+0.44%)

Sees Q4 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

06/16/22 Piper Sandler
Hain Celestial price target lowered to $31 from $36 at Piper Sandler
05/24/22 CL King
Hain Celestial initiated with a Buy at CL King
05/23/22 Cowen
Hain Celestial initiated with an Outperform at Cowen
05/09/22 Mizuho
Hain Celestial price target lowered to $31 from $44 at Mizuho
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

05/05/22
Hain Celestial sees 2022 flat adjusted net sales, consensus $1.95B
05/05/22
Hain Celestial sees Q4 low to mid single digital adjusted net sales growth
05/05/22
Hain Celestial reports Q3 adjusted EPS 33c, consensus 45c
  • 11
    Nov
Recommendations
Nvidia price target lowered to $250 from $290 at Mizuho » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
NVDA

Nvidia

$177.97 /

-11.97 (-6.30%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/08/22
Cathie Wood's ARK Investment bought 360K shares of Nvidia today
08/08/22
Nvidia falls 6.9% to $176.74 after negative Q2 revenue pre-announcement
07/20/22
Motorsport Games brings two titles to NVIDIA GeForce NOWNvidia
07/15/22
U.S. video game spending falls 11% y/y in June, says NPD
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/08/22 Summit Insights
Nvidia underestimated its exposure to crypto mining, says Summit Insights
08/08/22 Oppenheimer
Nvidia price target lowered to $250 from $300 at Oppenheimer
08/08/22 Truist
Nvidia price target lowered to $216 from $283 at Truist
08/08/22 Craig-Hallum
Craig-Hallum downgrades 'too expensive' Nvidia after guidance cut
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/08/22
Nvidia reports preliminary Q2 revenue $6.7B, consensus $8.1B
05/25/22
Nvidia sees Q2 revenue $8.1B, +/- 2%, consensus $8.45B
05/25/22
Nvidia reports Q1 EPS $1.36, consensus $1.29
05/25/22
Notable companies reporting after market close
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

07/28/22
House passes bill giving $52B to U.S. chipmakers, Bloomberg reports
07/28/22
Pelosi's husband sells Nvidia shares as House weighs chip bill, Reuters says
07/27/22
Senate pushes bipartisan chip bill to House to boost U.S, production, CNN says
07/19/22
New bill to provide $52B boost to US semiconductor manufacturing, WSJ reports
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/08/22
What You Missed On Wall Street On Monday
08/08/22
What You Missed On Wall Street This Morning
08/05/22
Here's What You Missed in Crypto This Week
07/29/22
Here's What You Missed in Crypto This Week
08/24/22
Nvidia - NVDA
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

07/21/22
NVIDIA call buyer realizes 58% same-day gains
06/21/22
Early notable gainers among liquid option names on June 21st
06/17/22
Notable open interest changes for June 17th
05/27/22
Notable open interest changes for May 27th
Recommendations
Freshpet price target lowered to $90 from $100 at Baird » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
FRPT

Freshpet

$56.39 /

+1.895 (+3.48%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

06/22/22
Freshpet recalls select product due to potential Salmonella contamination
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

05/20/22 Atlantic Equities
Atlantic Equities sees more volatility for Freshpet, downgrades shares
05/20/22 Atlantic Equities
Freshpet downgraded to Neutral from Overweight at Atlantic Equities
05/03/22 Cowen
Freshpet price target lowered to $163 from $181 at Cowen
05/03/22 Oppenheimer
Freshpet price target lowered to $110 from $120 at Oppenheimer
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

08/08/22
Freshpet backs FY22 revenue view of at least $575M, consensus $582.72M
08/08/22
Freshpet reports Q2 EPS (45c), consensus (14c)
05/02/22
Freshpet backs FY22 revenue view at least $575M, consensus $576.99M
05/02/22
Freshpet reports Q1 EPS (40c), consensus (39c)
  • 04
    May
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

08/08/22
Fly Intel: After-Hours Movers
05/20/22
Proven algorithm says sell these stocks now
05/20/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
05/13/22
Short Report: Upstart shorts take profits as stock craters on guidance cut
08/11/22
Freshpet
Earnings
Planet Fitness sees FY22 adjusted EPS up mid-80% range » 06:40
08/09/22
08/09
06:40
08/09/22
06:40
PLNT

Planet Fitness

$81.08 /

+0.71 (+0.88%)

Sees FY22 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

05/25/22
Blue Apron adds partnerships with Blue Cross Blue Shield, Planet Fitness
05/10/22
Planet Fitness announces development agreement in New Zealand
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22 Exane BNP Paribas
Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas
06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
06/07/22 Cowen
Planet Fitness positioned to succeed despite macro challenges, says Cowen
05/25/22 Cowen
Planet Fitness operating model remains resilient among headwinds, says Cowen
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

06:37 Today
Planet Fitness reports Q2 adjusted EPS 38c vs. 21c last year
05/10/22
Planet Fitness sees 2022 revenue increasing in mid-50 percent range
05/10/22
Planet Fitness reports Q1 adjusted EPS 32c, consensus 27c
05/09/22
Notable companies reporting before tomorrow's open
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
05/11/22
What You Missed On Wall Street On Wednesday
05/11/22
What You Missed On Wall Street This Morning
05/11/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
08:00 Today
Planet Fitness - PLNT
Recommendations
LivePerson price target lowered to $14 from $18 at Mizuho » 06:40
08/09/22
08/09
06:40
08/09/22
06:40
LPSN

LivePerson

$16.54 /

+0.775 (+4.92%)

Mizuho analyst Siti…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

07/21/22
LivePerson names Jill Layfield as lead independent director
07/21/22
LivePerson announces agreement with Starboard Value
07/21/22
LivePerson announces agreement with Starboard Value
06/02/22
LivePerson 'committed to engaging in constructive dialogue' with Starboard
LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

06:10 Today Loop Capital
LivePerson downgraded to Hold from Buy at Loop Capital
07/26/22 Jefferies
LivePerson price target lowered to $15 from $18 at Jefferies
05/23/22 Jefferies
LivePerson price target lowered to $18 from $23 at Jefferies
05/10/22 B. Riley
LivePerson price target lowered to $19 from $23 at B. Riley
LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

08/08/22
LivePerson lowers FY22 revenue view to $507.1M-$518.3M from $544.8M-$563.3M
08/08/22
LivePerson sees Q3 revenue $120.5M-$123.6M, consensus $140.45M
08/08/22
LivePerson reports Q2 EPS (98c), consensus (17c)
05/09/22
LivePerson reaffirms FY22 revenue view $544.8N-$563.3M, consensus $553.44M
LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

08/08/22
Fly Intel: After-Hours Movers
05/10/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
05/10/22
Fly Intel: Pre-market Movers
03/01/22
What You Missed On Wall Street On Tuesday

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.